University of Hong Kong Researchers Publish New Data on Disease Progression (Emerging EGFR-Mutated Subclones in a Patient With Metastatic ALK-Rearranged Lung Adenocarcinoma Treated With ALK-Targeted Therapy: A Case Report).

Předmět:	DISEASE progression ADENOCARCINOMA LUNGS METASTASIS CIRCULATING tumor DNA
Zdroj:	Drug Week; 8/4/2023, p1417-1417, 1p
Abstrakt:	Keywords: Adenocarcinoma; Brigatinib Therapy; Cancer; Disease Attributes; Disease Progression; Drugs and Therapies; Genetics; Health and Medicine; Lung Cancer; Lung Diseases and Conditions; Multikinase Inhibitors; Oncology; Pharmaceuticals EN Adenocarcinoma Brigatinib Therapy Cancer Disease Attributes Disease Progression Drugs and Therapies Genetics Health and Medicine Lung Cancer Lung Diseases and Conditions Multikinase Inhibitors Oncology Pharmaceuticals 1417 1417 1 07/31/23 20230804 NES 230804 2023 JUL 31 (NewsRx) -- By a News Reporter-Staff News Editor at Drug Week -- Fresh data on disease progression are presented in a new report. Adenocarcinoma, Brigatinib Therapy, Cancer, Disease Attributes, Disease Progression, Drugs and Therapies, Genetics, Health and Medicine, Lung Cancer, Lung Diseases and Conditions, Multikinase Inhibitors, Oncology, Pharmaceuticals. [Extracted from the article]
Databáze:	Complementary Index
Externí odkaz:	Zobrazit plný text záznamu